摘要
目的探讨序贯抗凝治疗缺血性脑血管病的临床疗效。方法40例频繁发生的短暂性脑缺血发作及进展性卒中患者,均经一般抗凝等治疗病情继续进展,给予口服华法林抗凝,进行疗效评价。结果40例患者痊愈率45%;显效率25%;好转率20%,无效率10%。结论临床序贯抗凝治疗缺血性脑血管病,治愈好转率高,后遗症少,是值得临床广泛应用的一种可行的治疗方法。
Objective To study the clinical therapeutic effect of sequential anti-coagulation therapy for ischemic cerebral vascular disease. Methods 40 frequent transient ischemic attact （ TIA ） or progressive ischemic stroke patients were studied. All the patients were given general anti-coagulation and other common therapy as well as oral uarfarin. The effects were compared. Results Of all the 40 patients,45% patients recovered completely,25% improved obviously,20% improved and 10% had no effects. Conclusion Comparing with general treatment, sequential anti-coagulation therapy can obtain a higher recovery rate when treating the patients with ischemic cerebral vascular disease and less sequels, so it may worth being widely used clinically.
出处
《中国医药》
2006年第9期531-532,共2页
China Medicine
关键词
缺血性脑血管病
华法林
序贯抗凝
Ischemic cerebral vascular disease
Uarfarin
Sequential anti-coagulation
